- Home
- SOFI vs ONC Comparison
SOFI vs ONC Comparison
Compare SOFI & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOFI | ONC |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 34.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SOFI | ONC |
|---|---|---|
| Price | $27.03 | $319.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 12 |
| Target Price | $24.70 | ★ $369.50 |
| AVG Volume (30 Days) | ★ 65.6M | 284.8K |
| Earning Date | 01-26-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 357.55 | N/A |
| EPS | 0.54 | ★ 0.58 |
| Revenue | $3,290,639,000.00 | ★ $4,972,687,000.00 |
| Revenue This Year | $37.00 | $895.40 |
| Revenue Next Year | $27.42 | $22.04 |
| P/E Ratio | ★ $50.32 | $545.67 |
| Revenue Growth | 30.62 | ★ 50.43 |
| 52 Week Low | $8.60 | $170.99 |
| 52 Week High | $32.73 | $385.22 |
Technical Indicators
Market Signals| Indicator | SOFI | ONC |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 41.76 |
| Support Level | $26.48 | $315.50 |
| Resistance Level | $27.68 | $326.77 |
| Average True Range (ATR) | 1.13 | 11.23 |
| MACD | -0.17 | -3.05 |
| Stochastic Oscillator | 32.84 | 18.85 |
Price Performance
Historical ComparisonAbout SOFI SoFi Technologies Inc.
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.